LAYLA ABUSHAMAT to Hypoglycemic Agents
This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Hypoglycemic Agents.
Connection Strength
0.831
-
Evolving Concepts of Type 2 Diabetes Management. Med Clin North Am. 2021 Nov; 105(6):955-966.
Score: 0.584
-
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity? Curr Cardiol Rep. 2024 Sep; 26(9):1011-1019.
Score: 0.178
-
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
Score: 0.038
-
Effect of Treating Vitamin D Deficiency in Uncontrolled Type 2 Diabetes: A Randomized, Placebo-Controlled Study. Am J Ther. 2019 Jul/Aug; 26(4):e441-e451.
Score: 0.031